Lab Personnel | Av-Gay Lab

Contents:

• YOSSEF AV-GAY
• AV-GAY LAB - PRINCIPAL INVESTIGATOR
• AV-GAY, YOSSEF
• PROF. YOSSEF AV-GAY, PHD
• YOSSEF AV-GAY
• AV-GAY LAB INTIFI FECTN-HALTG POUND, BROADLY EFFECTIVE OM COVID-19 TO THE MON LD

YOSSEF AV-GAY

Yossef Av-Gay. Yossef Av-Gay is a profsor the Divisn of Infect Diseas the Faculty of Medice.

Av-Gay’s rearch is geared towards the intifitn and characterizatn of novel dgs and dg targets Mybacterium tuberculosis. Av-Gay’s most signifint disvery was the intifitn and characterizatn of PtpA, a prote phosphatase Mtb which hibs the normal macrophage rponse to fectn.

AV-GAY LAB - PRINCIPAL INVESTIGATOR

Av-Gay received his BSc Blogy, MSc Microblogy, and PhD Microbial Geics – all om Tel Aviv Universy, Tel Aviv, Israel, and advanced trag at John Inn Instute, Norwich, UK, Albert Este Collage of Medice, New York and UBC partment of Microblogy. Av-Gay thored over 100 peer review scientific publitns, review articl, book chapters and 15 patents. Av-Gay served as an edor for the Journal of Blogil Chemistry (2010-2015), and on scientific advisory boards of several btechnology pani.

AV-GAY, YOSSEF

Av-Gay is a member of the scientific review panels of the Canadian Instute of Health Rearch (Microblogy and Infect Disease (2009-2016) and Foundatn and Project Grants (2016-), the French Agence Natnale la Recherche, Innovative Medice Innovatns, The UK wele Tst, US Natnal Instute of Health, and the European Commissn FP6, FP7 and Horizon 2020 programs. Richter A, Strch A, Chao J, Ko M, Av-Gay Y. Hekel F, Shen L, Richard-Greenblatt M, Gee CL, Gay LM, Okon M, Bui JM, Alber T, Av-Gay Y, Gsponer J and McIntosh LP.

Laqua K, Klemm M, Richard-Greenblatt M, Richter A, Liebe L, Huang T, L S, Guardia A, Pérez-Herran E, Ballell L, Av-Gay Y, Immg P. Wong D, Li W, Chao JD, Zhou P, Nala G, Tsui C, Ko M, Xie J, Martez-Frail C, Av-Gay Y. Tal A, Greenberg D, Av-Gay Y, Golan-Tripto I, Feste Y, Ben-Shimol S, Dagan R, Goldbart AD.

Tsui CKM, Wong D, Nala G, Gardy JL, Hsiao WWH, Av-Gay Y. Zheng X, Av-Gay Y. Margel D, Mizrahi M, Regev-Shoshani G, Ko M, Moshe M, Ozalvo R, Shav-Grievk L, Baniel J, Kedar D, Yossepowch O, Lifshz D, Nadu A, Greenberg D, Av-Gay Y.

PROF. YOSSEF AV-GAY, PHD

Richard-Greenblatt M, Av-Gay Y. Williams DE, Dalisay DS, Chen J, Polishchuck EA, Patrick BO, Nala G, Ko M, Av-Gay Y, Li H, Magarvey N, Anrsen RJ. Poirier V, Av-Gay Y.

Sai V, Cummg BM, Guidry L, Lamprecht DA, Adamson JH, Reddy VP, Chta KC, Mazorodze JH, Glasgow JN, Richard-Greenblatt M, Gomez-Velas A, Bach H, Av-Gay Y, Eoh H, Rhee K, Steyn AJ. Sorrento F, Gonzalez l R R, Zheng X, Pra Matilla J, Torr Gomez P, Martez Hoyos M, Perez Herran ME, Mendoza Losana A, Av-Gay Y.

Zhou P, Wong D, Li W, Xie J, Av-Gay Y.

YOSSEF AV-GAY

Richard-Greenblatt M, Bach H, Adamson J, Peña-Diaz S, Li W, Steyn AJ, Av-Gay Y. Hmama Z, Peña-Díaz S, Joseph S, Av-Gay Y. YOSSEF AV-GAY.

AV-GAY LAB INTIFI FECTN-HALTG POUND, BROADLY EFFECTIVE OM COVID-19 TO THE MON LD

Yossef Av-GayJanuary 13, 2022. Rearch Interts Host-Pathogen teractns, Microbial signal transductn, Tuberculosis Rearch Foc Teams COVID-19, Tuberculosis, Lung Disease Departments Infect diseas, Microblogy & Immunology Contact Email: yossi[at] Office Phone: 604–822–3432 Office number: 2503 Publitns Google Scholar Lab Webse Av-Gay lab.

Yossef Av-Gay – TB Vets.

Yossef Av-Gay, an fect disease profsor UBC’s faculty of medice and the study’s senr thor.